China - Vaccines For Veterinary Medicine - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingVeterinary Medicine Vaccines Prices in China
China Veterinary Medicine Vaccines Import Price in December 2021
In December 2021, the veterinary medicine vaccines price amounted to $212 per kg (CIF, China), which is down by -20.6% against the previous month. Overall, import price indicated a slight expansion from January 2021 to December 2021: its price increased at an average monthly rate of +1.6% over the last eleven months. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on December 2021 figures, veterinary medicine vaccines import price decreased by -20.6% against November 2021 indices. The growth pace was the most rapid in October 2021 an increase of 134% m-o-m. The import price peaked at $296 per kg in February 2021; however, from March 2021 to December 2021, import prices stood at a somewhat lower figure.
Prices varied noticeably by the country of origin: the country with the highest price was France ($1.2K per kg), while the price for Indonesia ($64.4 per kg) was amongst the lowest.
From January 2021 to December 2021, the most notable rate of growth in terms of prices was attained by France (+15.9%), while the prices for the other major suppliers experienced more modest paces of growth.
China Veterinary Medicine Vaccines Imports
For the third consecutive month, China recorded decline in overseas purchases of vaccines for veterinary medicine, which decreased by -34% to 64 tons in December 2021. Overall, imports faced a abrupt contraction. The most prominent rate of growth was recorded in March 2021 when imports increased by 205% m-o-m. As a result, imports attained the peak of 245 tons. From April 2021 to December 2021, the growth of imports remained at a somewhat lower figure.
In value terms, veterinary medicine vaccines imports fell markedly to $14M (IndexBox estimates) in December 2021. Over the period under review, imports continue to indicate a deep downturn. The most prominent rate of growth was recorded in October 2021 when imports increased by 104% m-o-m. Imports peaked at 51K tons in June 2021; however, from July 2021 to December 2021, imports remained at a lower figure.
China Veterinary Medicine Vaccines Imports by Country
In December 2021, the United States (49 tons) constituted the largest supplier of veterinary medicine vaccines to China, with a 76% share of total imports. Moreover, veterinary medicine vaccines imports from the United States exceeded the figures recorded by the second-largest supplier, the Netherlands (7.4 tons), sevenfold. The third position in this ranking was taken by Indonesia (6.9 tons), with an 11% share.
From January 2021 to December 2021, the average monthly rate of growth in terms of volume from the United States stood at -7.9%. The remaining supplying countries recorded the following average monthly rates of imports growth: the Netherlands (-16.1% per month) and Indonesia (-12.6% per month).
In value terms, the United States ($10M) constituted the largest supplier of veterinary medicine vaccines to China, comprising 75% of total imports. The second position in the ranking was taken by the Netherlands ($1.9M), with a 14% share of total imports. It was followed by France, with a 6.8% share.
From January 2021 to December 2021, the average monthly rate of growth in terms of value from the United States stood at -8.8%. The remaining supplying countries recorded the following average monthly rates of imports growth: the Netherlands (-11.5% per month) and France (-1.6% per month).
This report provides an in-depth analysis of the veterinary medicine vaccines market in China. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202160 - Vaccines for veterinary medicine
Country coverage:
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in China
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2024
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2024
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms, 2012–2024
- Market Value, 2012–2024
- Per Capita Consumption In 2012-2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country Of Origin, 2012–2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country Of Destination, 2012–2024
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2024
- Market Value, 2012–2024
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2024
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2024
- Trade Balance, In Physical Terms, 2012-2024
- Trade Balance, In Value Terms, 2012-2024
- Per Capita Consumption, 2012-2024
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2024
- Production, In Value Terms, 2012–2024
- Imports, In Physical Terms, 2012–2024
- Imports, In Value Terms, 2012–2024
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country Of Origin, 2012–2024
- Exports, In Physical Terms, 2012–2024
- Exports, In Value Terms, 2012–2024
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country Of Destination, 2012–2024
349
This report provides an in-depth analysis of the veterinary medicine vaccines market in China.
498
This report provides an in-depth analysis of the antisera market in China.
335
This report provides an in-depth analysis of the biological product market in China.
428
This report provides an in-depth analysis of the vaccine market in China.
307
This report provides an in-depth analysis of the market for human and animal blood in China.
645
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
1982
This report provides an in-depth analysis of the global antisera market.
427
This report provides an in-depth analysis of the global biological product market.
2592
This report provides an in-depth analysis of the global vaccine market.
496
This report provides an in-depth analysis of the global market for human and animal blood.
47
Merck has temporarily halted Gardasil shipments to China due to reduced demand, impacting 2025 revenue forecasts, while Keytruda sales remain strong.
64
Merck's earnings aligned with Wall Street expectations, yet stocks fell due to a lackluster 2025 forecast. The company's reliance on products like Gardasil and Keytruda amid Chinese market challenges is under scrutiny.
84
Spanish drugmaker Grifols SA navigates a challenging year with strategic shifts and investor concerns, aiming to stabilize financially and regain market confidence.
220
The article provides insights into the anticipated growth of the global market for antisera and other blood fractions over the next seven years, driven by increasing demand. Market performance is forecasted to expand with a CAGR of +1.7% in volume terms and +6.5% in value terms, reaching 707K tons and $580.4B respectively by the end of 2030.
661
Explore the top import markets for antisera and their key statistics. Find out which countries dominate the global import market for antisera and their import values.
1712
Global trade in antisera and other blood fractions reached the highest level ever, totalling near $182B in 2020. The U.S., Germany, China, Spain, the UK and South Korea top the world’s largest antisera exporter ranking, comprising 67% of the total shipments. More than half of antisera imports are supplied to Germany, the U.S., Austria, Spain, Italy, China and Switzerland.
1304
In 2016, the antisera and other blood fractions market grew by X% to X billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries.
1525
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
1595
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
3487
From 2007 to 2015, global exports of antisera and other blood fractions showed steady growth, amounting to X million USD in 2015. There was an annual increase of +X% throughout the analyzed period.
